Is Endometrial Cancer Risk Reduced by Oral Bisphosphonate Use?

J Clin Oncol. 2015 Nov 1;33(31):3670. doi: 10.1200/JCO.2015.62.0930. Epub 2015 Aug 17.

Authors

Federica Tomao¹, Nicoletta Colombo², Benedetti Panici³

Affiliations

¹ European Institute of Oncology, Milan; and University of Rome Sapienza, Rome, Italy federica.tomao@uniroma1.it.
² European Institute of Oncology, Milan, Italy.
³ University of Rome Sapienza, Rome, Italy.

PMID: 26282662
DOI: 10.1200/JCO.2015.62.0930

No abstract available

Publication types

Letter
Comment

MeSH terms

Diphosphonates / therapeutic use*
Endometrial Neoplasms / prevention & control*
Female
Humans
Postmenopause*
Risk Assessment / statistics & numerical data*

Substances

Diphosphonates